G protein-coupled receptors (GPCRs) mediate cellular signaling for a variety of stimuli, including light, ions, odorants, taste, neurotransmitters, and hormones, and they represent one of the largest gene families, with ≈1,000 members (≈3% of the genome). GPCR dysfunction underlies many diseases, and ≈40% of currently used drugs function through GPCRs, emphasizing their importance (1, 2) .
GPCRs have a common central core structure with a serpentine seven-transmembrane domain (7TM), and its conformational modulation after ligand binding transmits the activation signal through the cell membrane, mainly by activating heterotrimeric G proteins. In turn, G proteins trigger a cascade(s) of intracellular responses, including generation of second messengers, activation of kinases, and, finally, changes in gene expression. The dogma has been that upon GPCR activation, one ligand molecule binds to one receptor molecule. An alternative concept entails GPCR di/ oligomerization with receptor(s) of the same (homodimerization) or a different (heterodimerization) type. Clear evidence for the functional role of GPCR homo-and heterodimerization was first obtained for class C receptors, such as GABA B , taste (T1R 1-3 ) metabotropic glutamate (mGluR), and calcium-sensing receptors, where only dimers are involved in signal transduction (3, 4) . The information about the functional significance of in vivo di/oligomerization of the large class A GPCRs is controversial. Some class A GPCRs may function as monomers, as suggested by their ability to become activated when forced into the monomeric conformation (5) . Conspicuously, the information about the different modes of GPCR interactions has so far been obtained in cell culture experiments, and their significance in the physiological context in vivo remains open.
Besides signal transduction, some GPCRs are detected as di/ oligomers during their biosynthesis before membrane delivery (6) (7) (8) and ligand binding (9, 10) , and during their internalization after signal transduction (11, 12) . Likewise, di/oligomerization could explain the negative or positive receptor cooperativity (13, 14) , reconstitution of activation by mutant receptors (15, 16) , and ligand promiscuity (17) . The interactions of some GPCR dimers are covalent (18) (19) (20) (21) (22) , noncovalent (interactions involving the transmembrane domains or coiled-coil interactions; reviews, e.g., in refs. 2 and 23), or both (24) . Noncovalent interactions are likely to form very transient interactions (25) , fueling the debate on both the existence and functional significance of dimerization for class A GPCRs (26) (27) (28) (29) . Possibly, a liganded receptor interacts sequentially with another or multiple nonliganded receptors in its vicinity, pushing the equilibrium from an "active" to an "active-active" state (30, 31) . This could explain how the hypothetical cis ( Fig. 1A) and trans ( Fig. 1B) conformations of GPCRs result in G protein activation (32, 33) . The latter "intermolecular noncovalent cooperation," a term previously coined by Ng et al. (34) , has a broad implication in biological systems where a specific signal could be rapidly amplified, with minimal ligand binding, yet maintaining the specificity of action.
There is recent functional evidence that the class A GPCRs for glycoprotein hormones [i.e., of LH/choriongonadotropin (hCG), FSH, and TSH] could transduce their signal in cultured cells as di/ oligomers by trans-activation (8, 10, 14, 35) (Fig. 1B) , henceforth termed intermolecular cooperation. In this study, we used LHR, a glycoprotein hormone receptor, as a model to determine whether GPCR activation through intermolecular cooperation is physiologically relevant in vivo.
Results
Experimental Design and Rationale. We hypothesized that coexpression of binding-and signaling-deficient LHR mutants in transgenic (TG) mice in the absence of functional endogenous receptor (i.e., in the LHR knockout background) could restore LHR function by functional complementation. We selected two LHR mutant receptors for their inability to bind the ligand (LH or hCG) or to transduce signaling after ligand binding. The first mutant receptor (LHR LH− ) harbored an inactivating Cys 22 to Ala 22 mutation in the ligand binding extracellular domain (35, 36) . The second mutant (LHR cAMP− ) contained a deletion of TM helices 6 and 7 in exon 11 (amino acids deleted from Val 553 to Ala 689 ), and it was chosen because of involvement of the deleted region in G protein coupling and second messenger generation (37) . Furthermore, this region is a hotspot for inactivating LHR mutations (38) .
Intermolecular Cooperation and Di/Oligomerization of the Mutant
LHRs in Cell Culture. To confirm that the mutant receptors on their own were inactive and could cooperate intermolecularly, the mutant LHR cDNAs, and BAC clones harboring the same LHR mutants (SI Experimental Procedures and Fig. S1 ), were tested in transfected HEK-293 cells. As expected, LHR LH− showed no specific ligand binding and LHR cAMP− no signaling, but when the two receptor mutants were coexpressed, the cAMP response to hCG stimulation was partially restored (Fig. 1 C-E) , confirming earlier reports with similar receptor mutants (35) or even by more defective mutants, such as the exo-domain of the FSHR linked to a cell membrane phospholipid which is capable of activating a binding-deficient mutant (36) .
The expected transfer of the mutated receptors to the plasma membrane was studied by confocal immunofluorescence analysis. cDNAs encoding the two mutant receptors were N-terminally tagged with HA or FLAG, respectively, after the signal peptide (referred to as HA-LHR LH− and FLAG-LHR , are localized at the cell surface. Hence, the lack of transfer to the cell membrane is not the reason for the total lack of function of the two LHR mutants when expressed on their own ( Fig. 1 C and D) .
To demonstrate physical interaction (di/oligomerization) between the receptor mutants, HEK-293 cells expressing either or both of the tagged LHR mutants (see above) were lysed, followed by immunoprecipitation (IP) of the FLAG-tagged receptor (Methods). Whereas FLAG-tagged receptors (FLAG-LHR cAMP− ) could be observed after all IPs with the FLAG antibody (Fig. 2B) , HA-tagged LHR LH− could only be detected in immunoprecipitates from cells coexpressing both mutants with bands representing both monomers and SDS-resistant dimers (Fig. 2C, lane 5) . A control sample containing combined extracts of cells expressing one of the mutants separately, combined after lysis, indicated that the LHR LH− -LHR cAMP− interaction can only occur in cells expressing both mutants, and not as a conglomeration artifact (Fig. 2C, lane 4) . In another control experiment, we coexpressed FLAG-LHR cAMP− and HA-β2-adrenergic receptor (β2-AR) ( Fig. 2 B and C, lane 6) . FLAG antibody immunoprecipitation demonstrated presence of LHR di/oligomers, but no clear evidence for LHR-β2AR association could be shown upon immunoblotting with HA antibody.
Hence, LHR di/oligomerization under these conditions was specific and not a random phenomenon with other GPCRs.
To exclude the possibility that the apparent lack of activation of the mutant receptors as monomers depends on a low level of expression, we transfected HEK-293 cells with increasing amounts (up to 100 ng) of cDNAs encoding LHR cAMP− and LHR LH− (SI Results and Fig. S2 ). No cAMP generation was found either basally or in the presence of maximally stimulating hCG level (5 nM), indicating that the mutant receptors, even when highly expressed, are not able to restore signaling as monomers. The possibility of their activation as heterodimers with another functional GPCR was studied by cotransfecting the LHR cAMP− mutant with the β2-AR to HEK-293 cells (SI Results and Fig. S2 ). No activation of cAMP signaling was found either basally or in response to hCG. This finding corroborates the lack of LHR activation in the TG mice expressing one of the mutant LHRs (see below).
Generation of TG Mice. To investigate the possibility of LHR activation through intermolecular cooperation in vivo, we set out to modify bacterial artificial chromosome (BAC) clones containing the entire mouse LHR by homologous recombination, to obtain two mutant clones containing the same mutations as described above (Fig. S1 ). The use of BAC clones ensures normal spatiotemporal expression of the TG LHR mutants. Each BAC also contained a reporter gene for bicistronic expression, Dicosoma sp. red fluorescent protein (RFP) or enhanced cyan fluorescent protein (eCFP), respectively, downstream of the LHR cAMP− and LHR LH− genes, to be used for expression profiling and genotyping (for details, see SI Experimental Procedures and Fig. S1 ). Both LHR mutant BACs were then microinjected into fertilized FVB/N mouse oocytes by standard procedures. As the definitive experiments needed to be carried out in the LHR-null (LuRKO) background, we designed a breeding strategy to create intercrosses of each of the TG LHR mutants alone or together in the homozygous LuRKO background (LHR LH−/cAMP− ) (39) . The mutant LHR BAC clones contained modified areas differing from the WT or LuRKO loci, which could be used for genotyping of the TG animals, as well as to make sure that the transgenes did not integrate to the WT or LuRKO genomic alleles by recombination (Fig. S1 ). The transgene copy numbers were similar in the LHR LH- (3) (4) (5) (6) (7) (8) (9) (10) (11) and LHR cAMP-(2-8) lines (Table S1 ). The expression of both mutant LHR BAC transgenes at mRNA level was mainly confined to the gonads, with a low level of expression in the brain (Fig. 3A) , where LHR expression has been previously reported (40) . To determine the transgene expression at protein level, we analyzed the expression of the reporter genes [Discosoma sp. red fluorescent protein (RFP) or enhanced cyan fluorescent protein (eCFP)] (Fig. 4) . Due to the presence of high levels of cholesterol and its derivates, there was high autofluorescence background in the gonads, particularly in testicular Leydig cells (LC), which made it difficult to detect the reporter fluorescent proteins. To differentiate the reporter fluorescence from background, and to increase the signal, immunofluorescence of fixed testis sections was performed by using specific antibodies against RFP or GFP (which also detects eCFP). This confirmed that the expression of both transgenes was confined only to LC in the testes (Fig. 4) . In brain, the low expression observed at mRNA level (Fig. 3A) (Figs. 3 B and C) . While LHR mRNA levels in the single TG testes were half of that of the WT testes, they were over 2-fold higher in the double-TG testes (Table S2 ).
Both receptor mutants (LHR cAMP− and LHR LH− ) in the LuRKO background presented with phenotypes indistinguishable from LuRKO animals (39, 41) , with arrested postnatal sexual maturation, cryptorchid testes, small and poorly developed accessory sex organs, LC hypoplasia, spermatogenic arrest at the round spermatid stage (Figs. 4 and 5 A-C) and very low serum testosterone levels (Fig. 5F ). These results confirm that the mutant LHRs are completely inactive on their own also in vivo, and demonstrate that the mutant TG clones do not interact with the LuRKO alleles.
In striking contrast to the single mutants in LuRKO background, males expressing both LHR mutants (LHR LH−/cAMP− ) in this background showed complete rescue of the WT phenotype. The testes of these mice were descended to the scrotum and had normal weight and size. Accessory sex organs also were fully developed with normal size (Fig. 4 D and E, SI Results, and Table  S3 ); serum testosterone levels were in the WT range (Fig. 5F ). LC volume density and seminiferous tubule diameters were also similar in LHR LH−/cAMP− and WT mice (SI Results and Table S4 ). Further evidence for functionality of LHR signaling in the LHR LH−/cAMP− mice was provided by the serum LH levels, which, albeit slightly higher than in WT mice, were only approximately one-quarter of those measured in LuRKO mice, as the sign of gonadal negative feedback effect on gonadotropin secretion (Fig.  5F ). Full spermatogenesis and normal-sized interstitial LC islets were observed by histological analysis of the testes ( Fig. 5 D and E). Furthermore, the LHR LH−/cAMP− males were fertile and sired similar numbers of pups as WT males [7.1 ±1.9 vs. 7.5 ± 1.3, respectively (mean ± SD; n = 3-4)].
Finally, as clear evidence that the rescue of the phenotype was due to LHR-signaling in LCs, we measured the expression of two LH-dependent, LC-specific genes [steroidogenic acute regulatory protein (StAR; GenBank no. NM_011485) and P450, family 17, subfamily a, polypeptide 1 (Cyp17a1; GenBank no. NM_007809)] Table S5 ). There was no evidence for residual activity of either of the mutant receptors alone even when these mice had 10-fold higher serum LH levels than control WT animals throughout their life, without significant testosterone production or LH-dependent gene response.
Discussion
Our findings demonstrate cooperation between GPCRs because this is the only possibility for a binding-and a signaling-deficient receptor to restore normal hormone action in the physiological context. The evidence for di/oligomerization upon GPCR activation is still exclusively based on data from cell cultures and immunoblots of tissue extracts, which has left the functional significance of this phenomenon open and controversial. In earlier studies on cultured living cells, coexpression of binding-and signaling-deficient LHR mutants was able to partly rescue the intracellular cAMP response (33, 35) , as was also confirmed here ( Fig. 1) . Although cAMP is the key second messenger in LHR signaling, and a universal product of the activation of all GPCRs, these experiments cannot resolve how well the functional complementation can restore all physiologically important aspects of LHR function in vivo. Our current findings provide strong evidence that intermolecular cooperation is sufficient to restore all physiologically essential functions of LHR. To what extent this finding can be generalized to other GPCRs remains to be studied.
LHR expression from BACs was directed in a tissue-specific manner mainly to gonads, and more specifically to LC in male mice. Because neither receptor mutant alone was capable of restoring the WT phenotype, the result proves that both of them are functionally inactive also in vivo despite high LH levels ( Fig.  5F ). Moreover, the LHR cAMP− mutant was able to bind hCG in testis homogenates without any phenotypic signs of LHR activa- tion, and the LHR LH− mutant was not able to bind hCG. Previous cell culture studies on expression of complementary receptor mutants have shown that the observed intermolecular cooperation was not due to rescue of one mutant, trapped in the endoplasmic reticulum (ER), by the other to the cell membrane, but to direct interaction of two complementary mutants at the cell membrane (33, 35) , as was also the case with the intermolecular cooperation of FSHRs (36) . Furthermore, overexpression of the mutant receptors alone in HEK-293 cells could not demonstrate any cAMP signaling activity, indicating that the mutant receptors do not attain spurious activation as monomers even when overexpressed.
Further evidence that the intermolecular cooperation of LHRs is not the result of trafficking rescue through the ER by another receptor, but of direct cooperation between these mutants, is presented by the surface expression of both mutants separately. Moreover, immunoprecipitation of one tagged LHR associated with the complementary receptor indicated that these receptors physically interact with each other at the molecular level, and form homo-di/ oligomers (∼120 KDa, ∼240 KDa, and higher magnitude), similar to a recent report where LHR di/oligomers were detected by BRET (8) .
When both receptor mutants were coexpressed in TG mice in the LuRKO background, LHR signaling was restored to such an extent that it was able to normalize LC differentiation, gonadal development, sexual maturation, androgen production, and spermatogenesis. Finally, the mice were fertile and sired similar numbers of pups with WT controls. Interactions between the LHR mutants and other GPCRs are unlikely because the mice carrying single LHR mutations did not present any recovery of phenotype, and signaling-deficient LHR mutant overexpressed in HEK-293 cells with another GPCR (i.e., the β2-AR) did not dimerize or generate cAMP response. It is therefore likely that the homo-di/oligomer cooperation detected represents a normal physiological phenomenon in the activation and intracellular signaling of the LHR, and might also apply to other structurally similar GPCRs such as FSHR and TSHR. However, our findings do not exclude the possibility of functional receptor monomers; for example, the single α/β-hCG-LHR fusion protein forms a constitutively active complex (43) . Such a configurational flexibility is surprising because receptors maintain high ligand specificity while being able to form complexes with their ligands in different arrangements, e.g., gonadotropin α- and β-chains tethered into various dimeric or tetrameric orientations retain the bioactivity of the hormone-receptor complexes (44, 45) . To what degree such conformations recapitulate the fully physiological response remains to be studied. What is becoming clear is that LHR and FSHR di/oligomers are already formed in the ER during their biosynthesis (8, 10) .
Our approach to studying the GPCR intermolecular cooperation in vivo was made possible by the availability of the LuRKO mouse (39) . It was crucial that the mutant LHRs were expressed in the absence of functional WT receptors and completely inactive on their own. It was also important to have a model where the phenotype is so specific and clear that only the expected intermolecular cooperation of mutant receptors could rescue it.
Earlier cell culture studies have revealed quantitative difference in the cAMP and phosphoinositide responses of gonadotropin receptors upon their cis-and trans-activation (33, 36, 46) , but more pronounced qualitative differences in the responses to the two modes of receptor activation are possible. The only difference we found between the WT and LHR LH−/cAMP− mice was the 2-fold elevation of LH in the latter, suggesting that the trans-activated receptor complex is slightly less sensitive or less responsive to stimulation than the WT receptor. Lower binding affinity, smaller receptor density, or less efficient signaling are possible explanations for the difference. This was expected from the rescuing results on cultured cells where only partial cAMP activation is achieved.
The intermolecular cooperation upon LHR activation might provide answers to some questions hotly debated about GPCR diand oligomerization (26) (27) (28) (29) , because it suggests that the receptors, when in close physical contact, can activate another or several others in their vicinity after ligand binding. It could also contribute to the "spare receptor" concept, i.e., that a small proportion of liganded receptors is sufficient to evoke full biological response (47) . Most importantly, however, intermolecular cooperation may also occur between other GPCRs, adding to the complexity of these receptors interactions and their diversity in biological systems.
Methods
The bovine prolactin signal peptide was inserted by Red/ET recombination as for the BAC clone carrying the same mutant (see below). The entire coding region of each construct was sequenced to verify fidelity of the constructs. . Surface receptors were labeled with a rabbit anti-FLAG antibody or mouse anti-HA antibody using standard methods (see details in SI Experimental Procedures).
Immunoprecipitation. HEK-293 cells expressing either or both LHR mutants were collected using lysis buffer with protease inhibitors (50 mM Tris-HCl, pH 7.4, with 150 mM NaCl, 1 mM EDTA, and 1% TRITON X-100). The extracts were incubated on ice for 20 min followed by centrifugation for 15 min at maximal speed. For coimmunoprecipitation of differentially tagged LHRs, cell lysates were incubated overnight with anti-FLAG agarose affinity gel (A2220; Sigma) and then eluted with FLAG peptide (F4799; Sigma). Immunoprecipitates were separated by SDS-polyacrylamide-gel electrophoresis (SDS/PAGE) under reducing conditions, electroblotted onto a nitrocellulose membrane, probed with either an anti-FLAG antibody (F7425; Sigma) or an anti-HA antibody (sc-805; Santa Cruz), and horseradish peroxidase-conjugated goat anti-rabbit IgG (DAKO). The immunoreactive bands were visualized using an ECL detection system (Amersham Biosciences). , LHR cAMP− , and LHR LH−/cAMP− mice. Each bar denotes the mean ± SD of measurements from at least four mice. Different letters above the bars indicate that these levels differ significantly (P at least <0.05).
conditions of light (12 h light, 12 h dark) and temperature (21 ± 1°C) in the animal facility of the University of Turku. The mice were fed with mouse chow Special Diet Service RM-3 (E, soy free; Whitham) and tap water ad libitum. The University of Turku Ethical Committee on Use and Care of Animals approved all procedures of the current experiments. In all experiments WT and heterozygous littermates were used as controls. The animals were killed by overdose of Avertin and cardiac puncture was used for blood collection. Tissues were dissected out, weighed, and snap-frozen in liquid nitrogen, or fixed in 4% paraformaldehyde.
Immunofluorescence of Histological Sections. Whole-mount fixed testis sections were boiled in citric buffer (10 mM sodium citrate, 0.05% Tween-20, pH 6.0) for 10 min, washed and blocked with 10% normal goat serum (NGS) in PBS. Double immunofluorescent staining was performed using standard protocols and commercial mouse anti-RFP and rabbit anti-GFP (which also detects eCFP) antibodies (both MBL International). As secondary antibodies (Molecular Probes), goat anti-rabbit conjugated to Alexa Fluor-488 (green) for eCFP and goat anti-mouse Alexafluor-594 (red) for RFP were used. Nuclei were permeabilized in the last wash with PBS-Triton (0.1%) and stained with DAPI (Vector Laboratories) before mounting with VECTASHIELD antifading medium (Vector Laboratories) (see SI Experimental Procedures for additional details about experimental settings). Images were captured on a Leica DMRBE fluorescent microscope (Leica Microsystems), imaged with a CCD camera using IM500 (Leica) and cropped in Adobe Photoshop.
RT-PCR and Genotyping. Standard protocols were followed. Briefly, RT-PCR amplification of total mRNA extracted from different tissues and purified by RNeasy kit (Qiagen) was performed with AMV-reverse transcriptase (Promega) following the manufacturer's instructions, using primer pairs F1 and R1 (SI Experimental Procedures). PCR was performed using BioTools polymerase and buffer. The presence of the transgenes was determined by screening tail DNA using the PCR primer pairs shown in SI Experimental Procedures.
Quantitative RT-PCR (qPCR). Isolated mRNA from tissue or cell culture samples where analyzed by standard protocols using a SYBR-green kit (DyNAmo; Finnzymes) and a Chomo4 thermo-cycler (Bio-Rad). Primer details are in the SI Experimental Procedures.
Statistical Analyses. ANOVA was used for statistical analyses, followed by Tuckey-Kremer multiple comparisons post hoc test to identify the groups differing. All numerical data are presented as the mean ± SD, and P < 0.05 was considered statistically significant. 
Supporting Information
Rivero-Müller et al. 10 .1073/pnas.0906695106 SI Experimental Procedures LHR cDNA Mutants. Oligonucleotide-mediated site-directed mutagenesis was performed by using the QuikChangeII Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer's instructions. Clones selected by ampicillin were directly sequenced to verify that they contained the correct mutation. The entire sequence of each mutant cDNA was determined.
The LHR mutants (LHR LH− and LHR cAMP− ) as cDNAs were then subcloned into an expression vector pDNA3.1(-) (Invitrogen) between the restriction site of EcoRI and BamHI and tagged with HA or FLAG into the N-terminal coding sequence just after the signal peptide (referred to as FLAG-LHR cAMP− and HA-LHR LH− ). The entire coding region of each cDNA construct was sequenced to verify the different modifications.
BACs and Recombination. A BAC clone carrying the entire mouse LHR gene (RPCI23-18D7) was obtained from the BAC PAC resources of Oakland Children's Hospital in E.coli strain HS996. The C22A mutation (LHR LH− ) was adjusted by a mouse codon usage program (www.entelechon.com). The point mutation in LHR LH− and ΔTM67 deletion in LHR cAMP− were achieved by inserting and replacing a selection/counter selection cassette (RpsL-Neo) with single strand oligonucleotides (1) (see below for primer sequences). Bicistronic reporter cassettes were inserted by Red/ET recombination and screened with specific primers. Prolactin signal sequence was inserted by the ALFIRE procedure (2), first by inserting an RpsL-Neo cassette flanked by ISce-I restriction sites and homology arms to the bovine PRL signal sequence from a previously described vector (3). All areas of modification were sequenced to ensure correctness. PCR amplification for recombineering was performed using TripleMaster polymerase mix and buffers (Eppendorf). BAC DNA was propagated in bacteria by standard procedures and purified using a Large construct Maxiprep kit (Qiagen), linearized, PFGE gelpurified and injected into the pronucleus of fertilized mouse oocytes using standard procedures. Additional details about the experimental settings and oligos are below.
Tissues for Immunofluorescence, RT-PCR, and Receptor Binding Assays.
Blood, testes, seminal vesicles, and other organs were collected, and their weights were recorded. Serum was separated by centrifugation, frozen, and stored at -20°C until used for hormone assays. After removal, one of each pair of testes was immediately frozen in liquid nitrogen and stored at -70°C until used for LHR binding and mRNA measurements. The other testis was fixed in freshly prepared 4% paraformaldehyde at 4°C, dehydrated with ethanol, and embedded in paraffin for immunofluorescence or immunohistochemistry.
Immunofluorescence of Histological Sections. Whole-mount fixed testis sections were boiled in citric buffer (10 mM sodium citrate, 0.05% Tween-20, pH 6.0) for 10 min, washed and blocked with 10% normal goat serum (NGS) in PBS. Then, double immunofluorescent staining was performed using standard protocols and commercial mouse anti-RFP and rabbit anti-GFP (which also detects eCFP) antibodies (both MBL International Antibodies) diluted in PBS (0.05% goat serum) 1:100. Sections were incubated with primary antibodies overnight at 4°C, and thereafter washed twice in PBS before exposure to the secondary antibodies (1:500) (Molecular Probes), goat anti-rabbit conjugated to Alexafluor-488 (green) for eCFP and goat anti-mouse Alexafluor-594 (red) for RFP, for 1h at room temperature. Nuclei were permeabilized in the last wash with PBS-Triton (0.1%) and stained with DAPI (Vector Laboratories) (dilution 1:10,000) for 5 min before mounting with Vectashield antifading medium (Vector Laboratories). Images were captured on a Leica DMRBE fluorescent microscope (Leica Microsystems), imaged with a CCD camera using IM500 (Leica) and cropped in Adobe Photoshop.
Determination of BAC Transgene Copy Number by qPCR. The number of copies of each transgene in the genome of founder animals was measured by qPCR using DyNAmo SYBR Green (Finnzymes) and standard procedures. Genomic DNA was isolated as described (4), precipitated with ethanol and resuspended in 10 mM Tris-HCl, pH 8.5. Genomic DNA from different mouse samples was measured by UV spectrophotometer and adjusted to 5 ng/μL. PCR reactions were performed in duplicate in 20 μL using 96-well plates (Bio-Rad) in a qPCR thermocycler (Chromo4 with OpticonMonitor software, Bio-Rad), containing primers that recognize both WT and TG sequences. Specific primers that detect only endogenous WT receptor gene (as for genotyping LuRKO mice) were also used for normalization of the samples and standardization of TG copy numbers. A linear standard curve was drawn using WT genomic DNA at different dilutions. Considering that WT genome contains 2 copies of the LHR gene, the extra number of copies in the founder TG animals was considered as TG copies according to the trend line equation and dilution used. The following conditions were used: 95°C for 15 min, followed by 40 cycles of 94°C for 20 s, 56°C for 45 s, 72°C for 1 min, 80°C for 1 s. and LHR cAMP− mutants to generate cAMP signal, either basally or in response to hCG, HEK-293 cells previously seeded onto 96 well plates were transfected with high dose of 100 ng of the receptor cDNAs, using Lipofectamine 2000 (Invitrogen) transfection reagent. cAMP generation was monitored by cotransfection with 40 ng of a cre-luciferase plasmid DNA, and using 5 n of pRL-CMV as a transfection control. The total concentration of transfected DNA was standardized using pcDNA 3.1. Forty-eight hours after transfection, cells were stimulated with 0, 0.05, 0.5 and 5 nM hCG for 4 h and assayed for cre-luciferase and pRL-CMV activity using Luclite substrate solution (Perkin-Elmer), and coelenterazine substrate (Calbiochem) respectively. Luminescence was determined using a Victor2 plate-reading Luminometer (Perkin-Elmer). In another experiment, plasmids encoding β2-adrenergic receptor (β2-AR) and the LHR cAMP− mutant were cotransfected (100 ng of each) with creluciferase plasmid as above, and assayed for luciferase activity in the absence and presence of 0.05 and 0.5 nM hCG.
Immunofluorescence Staining of Tagged Receptors by Confocal
Imaging. Visualization of the tagged LHR molecules was carried out using indirect immunofluorescence microscopy of HEK-293 cells stably transfected with N-terminally tagged LHR either HA-WT, HA-LHR LH− or FLAG-LHR cAMP− . Surface receptors were labeled by 'feeding' the live intact cells either with a rabbit anti-FLAG antibody (1:500, Sigma) or mouse anti-HA antibody (1:250, Covance) for 20 min at 37°C, before fixation (4% paraformaldehyde in PBS, 20 min), followed by incubation for an additional 15 min in the absence (nonpermeabilized) or presence of the 0.02% Nonidet P-40 in PBS with 2% FBS for 15 min (permeabilized). Cells were then washed extensively with PBS and further incubated for 30 min with goat anti-mouse or goat anti-rabbit Alexa Fluor 488-conjugated antibodies (1:1000, Invitrogen) in blocking solution. Specimens were washed extensively in PBS, mounted on glass slides, and examined using a Leica SP5 laser scanning confocal microscope with a 63×/1.4NA oil immersion objective, using instrument settings verified to produce negligible bleed through between channels and an estimated section thickness of 1 μm. Micrographs shown are representative optical sections imaged through the center of the cell.
Immunoprecipitation. HEK-293 cells expressing either or both LHR mutants, or both LHR −cAMP and β2-AR (a gift from Mark von Zastrow, Univeristy of California San Francisco) were washed 48 h after transfection, and collected using lysis buffer with protease inhibitors (50 mM Tris-HCl, pH 7.4, with 150 mM NaCl, 1 mM EDTA, and 1% TRITON X-100). The extracts were incubated on ice for 20 min followed by microfuge centrifugation for15 min at maximal speed. Protein concentrations in the supernatants were measured using the Bradford assay. For coimmunoprecipitation of differentially tagged LHRs, and differentially tagged LHR −cAMP and β2-AR, one-mL aliquots of cell lysates were incubated overnight with 40 μL of anti-FLAG agarose affinity gel (A2220; Sigma) and then eluted with FLAG peptide (F4799; Sigma). Immunoprecipitates were separated by SDS polyacrylamide-gel electrophoresis (SDS/PAGE) under reducing conditions, electroblotted onto a nitrocellulose membrane, probed with either an anti-FLAG antibody (F7425; Sigma) or an anti-HA antibody (sc-805; Santa Cruz Biotechnology), and horseradish peroxidaseconjugated goat anti-rabbit IgG (DAKO). The immunoreactive bands were visualized using an ECL detection system (Amersham Biosciences).
mRNA Expression by qPCR. Quantitative PCR was performed by standard protocols using DyNAmo SYBR Green (Finnzymes) kit. PCR reactions were performed in triplicate in 20 μL using 96-well plates (Bio-Rad) in a qPCR thermocycler (Chromo4 with OpticonMonitor software, Bio-Rad), using primers that recognize LHR (WT and mutants, see below). For normalization of the samples a housekeeping gene (Ppia) was used. A linear standard curve was drawn using different dilutions of a plasmid containing the cDNA of the LHR. Results are expressed as the number of LHR/Ppia versus WT control.
The same procedure was used to determine the level of expression of LH-dependent Leydig cell-specific StAR and Cyp17a1 genes in testes of the different mutant mice, and result are presented below as percentage of WT controls.
LHR Binding Measurements. [
125 I]-hCG binding to testicular homogenates was measured as previously described (5, 6) . Briefly, a piece of the frozen testis (see above) was homogenized with an Ultra-Turrax 18/10 homogenizer in Dulbecco's PBS (100 mg testis/mL) containing 0.1% (wt/vol) BSA (Sigma Chemical), and 100 μL aliquots were used for binding measurements. 125 I]-hCG and increasing concentrations of cold hCG (0-10 nM). Incubations were terminated by addition of 4 mL ice-cold Dulbecco's PBS-BSA. Bound and free hormone were separated by centrifugation at 3,000 x g for 30 min. The supernatants were discarded, and the radioactivity in the pellets was measured in a γ-counter (1470 Wizard, Wallac).
Measurement of Tubule Diameter and Leydig Cell Volume Density.
Tubule diameters and Leydig cell volume densities of testis samples were measured from paraffin sections stained with eosinhematoxylin using a Leica microscope and Leica IM1000 software (Leica). Sections from three animals per group were analyzed, all tubules in three sections were measured. In the same way, Leydig cell volume densities were measured and calculated as percentage (%) of the total area of the section.
Oligonucleotides. All of the short primers (20-30 nts) described in this paper were purchased from TAG. All longer primers (60-140 nts) were purchased from Thermo. LHR cDNA mutants. The primers used to create the C22A, (LHR LH− ) mutant:
5′-GCCGGATGGTGCCCTGCGCGCACCTGGCCCTCGA-GCTGGC-3′ and 5′-GCCAGCTCGAGGGCCAGGTGCGCG-CAGGGCACCATCCGGC-3′.
The primers used to create DTM67 (LHR cAMP− ) mutant: 5′-ACGTTAGGATATACTTTGCAACAACCTACACCTCC-AAGAG-3′ and 5′-CTCTTGGAGGTGTAGGTTGTTGCAAA-GTATATCCTAACGT-3′.
Primers used to insert FLAG epitope: 5′-CACAGCTGCACTCTGATTACAAAGATGATGATGA-TAAGCCAGAGTTGTCAGGGTCG and 5′-CGACCCTGAC-AACTCTGGCTTATCATCATCATCTTTGTAATCAGAGTG-CAGCTGTG.
Primers used to insert HA epitope: 5′-CACAGCTGCACTCTTACCCATACGATGTTCCAGAT-TACGCTCCAGAGTTGTCAGGGTCG and 5′-CGACCCTGA-CAACTCTGGAGCGTAATCTGGAACATCGTATGGGTAA-GAGTGCAGCTGTG.
For modification of the LHR gene in BAC clones using Red/ET recombination.
Selection/counter selection cassette, RpsL-Neo, (CS) was amplified with primers containing homology arms for the region to be modified, then RpsL-Neo cassette was exchanged by a single strand (ss) oligonucleotide. -R 5′-GGGGGGGGGGAGGGAGAGGTTACTGAATTAACAC-TCTTGGAGGTGTAGGTTGTCAGAAGAACTCGTCAAGA-AGGCG-3′; ssLHR cAMP− 5′-GTGGCCTTTGTCGTCATCTG-TGCTTGCTACGTTAGGATATACTTTGCACAACCTACAC-CTCCAAGAGTGTTAATTCAGTAA-3′ For insertion of the reporter genes. Both reporter genes (eCFP and RFP) were amplified by PCR from bicistronic vectors containing a common IRES and polyA, which were used for the primer binding sites. Reporter gene insertion after the LHR gene were performed before other modifications using the following primers:
IRES-XFP-LHR-F 5′-CCATAGTGCACTGTCAACAACCT-ACACCTCCAAGAGTGTTAATTCAGTAACCTCTCCCTCC-CCCCCCCCTAAC-3′; and IRES-XFP-LHR-R 5′-TTTGGGT-GGACTTTTTTGGGGGGAACATATTTAGATACAATTCA-GTAATGGCAGTGAAAAAAATGCTTTATTTG-3′.
Insertion of the PRL signal sequence by ALFIRE ALFIRE-LHR-F 5′-GTCCAGCATACTGGCCTAGCCACC-GGAGCTCACACTCAGGCTGGCGGGCCATGGACAGCA-AAGGTTCGTCGCAGAAAGGGTCCCGCCTGCTCCTGCT-GCTAGGGATAACAGGGTAATGGCCTG-3′; and ALFIRE-LHR-F 5′-GGACCTGGGGCGCCCTGTACTCACAGTCGGG-CGAGGCCAGCTCGAGGGCCAGGGCAGCGCAGGGCGC-CGTCGGGCACGCAGTTGCAGGGCTCAGGGCAGGATT-GGCACAAGAATTACCCT-3′
Primers for genotyping IRESF 5′-GTATTCAACAAGGGGCTGAAGG-3′; CFP-R 5′-TTGATCCTAGCAGAAGCACAGG-3′; and RFP-R 5′-CC-ATGGTCTTCTTCTGCATCAC-3′
Primers for RT-PCR  F1 5′-TACCCTTACAGTCATCACTCTGGA-3′; and R1 5′-TTCAAGAAGCTTCCAGAGGAAC-3′ Primers for qPCR (TG copy number) F1 5′-AGCATCTGTAACACAGGCATCC-3′; and R1 5′-CA-CAGCGTGATGGACTCATTAT-3′
Primers of qRT-PCR Total mLHR expression F 5′-AGCATCTGTAACACAGGCATCC-3′; and R 5′-CA-CAGCGTGATGGACTCATTAT-3′
Primers for StAR (GenBank NM_011485) F 5′-CAGGGAGAGGTGGCTATGCA-3′; and R 5′-CCGT-GTCTTTTCCAATCCTCTG-3′
Primers for Cyp17a1 (GenBank NM_007809) F 5′-GGCCCCAGATGGTGACTCT -3′; and R 5′-GGACT-CCCCGTCGTATGTAA -3′
Primers for housekeeping gene peptidylprolyl isomerase A (Ppia, GenBank NM_008907) F 5′-CATCCTAAAGCATACAGGTCCTG-3′; and R 5′-TC-CATGGCTTCCACAATGTT-3′
SI Results
Weights of the LuRKO, LHR LH− and LHR cAMP− testes were approximately one third of those of WT mice, whereas the LH LH−/cAMP− testes did not differ from the latter (Table S3 ). Seminal vesicles of the LuRKO, LHR LH− and LHR cAMP− mice were rudimentary, whereas the WT and LHR LH−/cAMP− seminal vesicles had similar weights (Table S3) .
Seminiferous tubular diameters and Leydig cell volume densities of the LuRKO, LHR LH− , and LHR cAMP− testes were similar and narrower/smaller than in the LHR LH−/cAMP− and WT testes, which did not differ from each other (Table S4) .
Transgene copy numbers were similar in the LHR LH− (3-11) and LHR cAMP− (2-8) mice (Table S1 ). With maximal amounts (100 ng) of LHR LH− or LHR cAMP− plasmids were transfected into HEK-293 cells, no cAMP signal (measured by cre-luciferase activity) was detected either in the absence or presence of hCG (0.05, 0.5, and 5 nM) (Fig. S2) , indicating that overexpression of one of the mutants alone is not able to activate cAMP generation, which was readily detected in cells expressing WT receptor. Likewise, cotransfection (100 ng each) of the LHR cAMP− mutant and β2-AR expression plasmids did not produce cAMP signal basally or in response to hCG stimulation (Fig. S2) . Robust activation of signaling was observed in each case when WT LHR was transfected.
Total mLHR expression of different mutants was compared to WT controls, whereas LHR single mutants express ∼60% of control levels, the double mutant (LHR LH−/cAMP− ) overall expresses 2.3 times the LHR levels than WT (Table S2) .
LH-dependent Leydig cell-specific genes (StAR and Cyp17a1) were analyzed by quantitative PCR to show the direct activation of cell signaling in Leydig cells by LH. Negligible expression of either gene could be detected in LHR single mutants and LuRKO mice samples, whereas LHR LH−/cAMP− and WT expressed both genes (Table S5) at near similar levels. Each value is the mean ± SD of measurements from at least four mice. Groups with different superscripts differ significantly (P < 0.001). N/A, not applicable because the size of the seminal vesicles in LuRKO, LHR LH− , and LHR cAMP− mice was too small for accurate measurement. Each value is the mean ± SD of at least three samples. Groups with different superscripts differ significantly (P < 0.001 for seminiferous tubular data; P < 0.05 for Leydig cell data). Leydig cell volume density (% of total section) was calculated as the area covered by Leydig cells in a testicular histological section divided by the total area of the section. 
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Genomic DNA of two founder mice per group in duplicate was analyzed by real-time PCR. Copy numbers were calculated after subtraction of the WT copy number (considered = 2) and calculated on a linear standard curve created by dilutions of WT genomic DNA.
